abstract BACKGROUND: Low case volume has been associated with poorer surgical outcomes in a multitude of surgical procedures. We studied the association among low case volume, outcomes, and the likelihood of pediatric liver transplantation.
METHODS:
We studied a cohort of 6628 candidates listed in the Organ Procurement and Transplantation Network for primary pediatric liver transplantation between 2002 and 2012; 4532 of the candidates went on to transplantation. Candidates were divided into groups according to the average volume of yearly transplants performed in the listing center over 10 years: .15, 10 to 15, 5 to 9, and ,5. We used univariate and multivariate Cox regression analyses with bootstrapping on transplant recipient data and identified independent recipient and donor risk factors for wait-list and posttransplant mortality.
RESULTS: 38.5% of the candidates were listed in low-volume centers, those in which ,5 transplants were performed annually. These candidates had severely reduced likelihood of transplantation with only 41% receiving a transplant. For the remaining candidates, listed at higher volume centers, the transplant rate was 85% (P , .001). Being listed at a low-volume center was a significant risk factor in multivariate Cox regression analysis for both wait-list mortality (hazard ratio, 3.27; confidence interval, 2.53-4.23) and posttransplant mortality (hazard ratio, 2.21; confidence interval, 1.43-3.40).
CONCLUSIONS: 38.5% of pediatric transplant candidates are listed in low-volume transplant centers and have lower likelihood of transplantation and poorer outcomes. If further studies substantiated these findings, we would advocate consolidating pediatric liver transplantation in higher volume centers.
WHAT'S KNOWN ON THIS SUBJECT:
Low case volume has traditionally been associated with poor outcomes in complex surgical procedures, including pediatric liver transplantation.
WHAT THIS STUDY ADDS:
This retrospective analysis supports the association between low case volume and poorer outcomes in pediatric liver transplantation, and, in addition, shows that candidates listed in low-volume centers have severely limited access to transplantation. Traditionally, research has shown an association between low case volume and poor outcomes in a multitude of surgical procedures, [1] [2] [3] [4] [5] such as hysterectomy, 6 pancreatectomy, 5, 7 esophagectomy, 5 pelvic exenteration, 5 and coronary artery bypass surgery. 2, 8, 9 Studies have also shown this relationship in several pediatric procedures of varying complexity, such as cardiac surgery, 10, 11 pyloromyotomy, 12 appendectomy, 13, 14 and inguinal hernia repairs. 13, 14 In the field of transplantation, a landmark manuscript published in 1999 suggested that programs performing ,20 transplants per year had inferior outcomes. 15 Although several studies have refuted these conclusions, 16, 17 other investigations into all types of solid organ transplants have upheld the relationship between low volume and poor outcomes. [18] [19] [20] [21] [22] Specifically in the field of pediatric liver transplantation, researchers working with the Scientific Registry of Transplant Recipients database have shown inferior outcomes in transplantation associated with lowvolume centers. 14 In this study, we used multivariate analysis to investigate the relationship between wait-list and transplant outcomes and pediatric transplant liver center volume. We sought to look beyond these outcomes by analyzing the effect of center volume on transplant access.
Allocation of pediatric livers for transplantation is designed to serve the sickest patients first. These patients with acute liver failure are designated Status 1A, whereas Status 1B is reserved for very sick chronically ill pediatric patients. Aside from these special status categories, the priority for transplantation is based on the Pediatric End-Stage Liver Disease (PELD) score for children aged #11 years and on the Model for End-Stage Liver Disease (MELD) score for children aged from 12 to 18 years. The PELD score is a model for wait-list mortality that includes bilirubin, international normalized ratio, albumin, growth failure, and age ,1 year. The MELD score includes international normalized ratio, bilirubin, and creatinine. When a pediatric liver donor becomes available, it is first offered to Status 1A children in the United Network for Organ Sharing (UNOS) region and then nationally. Subsequently, it is offered to Status 1 adults, to Status 1B children, to children 0 to 11 years in order of decreasing PELD scores in the UNOS region, and to children 12 to 18 also in decreasing order of MELD scores. Transplant center characteristics do not affect allograft allocation; only candidate characteristics are considered.
FIGURE 1
Dot plot with logarithmic trendline. Abscissa number of yearly transplants. Ordinate transplant rate over the study period. were excluded. Retransplantation candidates were also excluded (n = 1064). From the date of listing, 6628 patients were followed, and 4532 candidates received a transplant during the study period. All patients were followed to either death (n = 1171) or the date of last known follow-up (n = 5457).
Statistical Analysis
Data were analyzed by using a standard statistical software package, Stata 9 (Stata Corp, College Station, TX). Continuous variables were reported as mean 6 SD and compared using the Student t test and the Mann-Whitney U test. Contingency table analysis was used to compare categorical variables. A P value ,.05 was considered significant, and all reported P values were 2-sided. A hazard ratio (HR) .1 indicates a greater risk of mortality.
Probability of Transplant Analysis
The primary outcome measure was transplantation. All listed candidates were included in the analysis (n = 6628). Patients who died were censored. Time to transplantation was assessed as time from date of listing to date of transplantation.
Wait-List Survival Analysis
The primary outcome measure was death on the wait list. All listed candidates were included in the analysis (n = 6628). Candidates were not removed from the analysis if they were taken off the wait list. Death was established by the UNOS death date and social security death master files.
Time to death was assessed as the 
Posttransplant Survival Analysis
The primary outcome measure was death after transplantation. Only recipients who underwent transplantation were included in this analysis (n = 4532). Time to death was assessed as the time from date of transplantation to date of death.
Intent-to-Treat Analysis
The primary outcome measure was death, regardless whether it was posttransplant or wait-list death.
Candidates were followed from time of listing (n = 6628) to time of death or last known follow-up, regardless of transplantation. UNOS death date and social security master death files were used to establish death. Time to death was assessed as the time from date of listing to date of death.
Kaplan-Meier analysis with log-rank test and Cox regression were used for time-to-event analysis. Survival, on the wait list or posttransplant, was the dependent variable, and the risk factors were the independent variables in the regression analysis. Risk factors that were significant in univariate analysis (P , .05) were included in the multivariate analysis. Multivariate Cox regression was performed combining 100 bootstraps. Patients lost to follow-up or alive on December 31, 2012, were censored at the date of last known follow-up.
Risk Factors
Pediatric liver-transplant volume for each center was the average number of cases performed from 2002 to 2012. Centers were categorized as low volume when their records showed ,5 cases performed per year. The slope of the curve is steepest between 0 and 4 cases per year (Fig 1) . Kaplan-Meier curve of probability of liver transplant by center volume. *P , .001 for each group by log-rank test with reference to ,5 transplants per year. support, artificial liver, or a write in entry for another mechanism.
Missing Variables
Multiple imputation with predicted mean matching was performed for the following incomplete predictors in the Organ Procurement and Transplantation Network database: serum sodium (25.3%), cold ischemia time (9.0% missing), serum creatinine (6.9%), ascites (5.8%), encephalopathy (5.7%), recipient weight (4.1% missing), diagnosis (0.4%), PELD score (0.3%), recipient height (0.1% missing), albumin (0.1%), and Status 1 (0.1%). We found no significant difference in the missing variables between low-and higher volume centers. We also found no significant differences in our survival models if serum sodium was removed.
Candidates' Removal From the Wait List for Conditioned Improved
These candidates were removed from the wait list for improvement in their medical condition. They did not receive a transplant at a later date or die within our study period.
Geographic Variation
To investigate clustering of low-volume centers in particular UNOS regions, we compared the proportions of low-volume listings to overall listings among UNOS geographic regions.
RESULTS

Data Entry Rate
Data entry completion for variables is listed in Table 1 . Most variables were well populated. Multiple imputation with predicted mean values was performed for missing variables.
Study Population
The study population at the time to transplant and wait-list survival analysis consisted of 6628 patients. Wait-list analysis comprised 4554 years-at-risk for liver transplant recipients. Mean follow-up was 0.7 years. The study population for the posttransplant survival analysis had 4532 patients. Posttransplant survival analysis comprised 22 549 years-atrisk for liver transplant recipients. Mean follow-up was 5.0 years. Demographic and clinical characteristics are summarized in Table 2 .
Transplant Rate
Centers with .15 transplants a year had a transplant rate over the study period of 83%; those with 10 to 15 transplants per year, 94%; 5 to 9
FIGURE 3
Kaplan-Meier curve of wait-list survival by pediatric liver center volume P , .001 for each group by log-rank test with reference to ,5 transplants per year. transplants per year, 84%; and .5 transplants per year, 41%. Figure 1 shows the dot plot of transplant rates for each center's transplant volume. Figure 2 shows the Kaplan-Meier curve of the probability of transplantation.
Wait-List Survival Analysis
The recipient and center risk factors listed in Table 1 were considered. Risk factors that were significant in multivariate analysis are presented in 
Posttransplant Survival Analysis
The risk factors listed in Table 1 were considered. Risk factors that were significant in multivariate analysis are presented in Table 4 . The most significant risk factors were hepatoblastoma (HR 3. 
Intent-to-Treat Analysis
The Kaplan-Meier curve for survival of all listed candidates from time of listing is shown in Fig 5 .
Cadaveric Technical Variant Grafts
Centers performing ,5 transplants per year used cadaveric technical variant grafts 18% of the time. This percentage was significantly smaller (P , .001) than the percentages of the other volume groups: 5 to 9 transplants per year, 29%; 10 to 15 transplants per year, 29%; and .15 transplants per year, 29%.
High-Risk Recipients
The survival of recipients under 6 kg treated in centers performing . .6%, and 10-year survival of 63.3%. The P value was ,.001 for each group by log-rank test with reference to .15 transplants per year.
Candidate Status at the End of Follow-up
The candidate status at the end of follow-up on December 31, 2012, including alive posttransplant, dead posttransplant, alive on the wait list, and dead on the wait list is reported in Table 2 .
Candidates Removal From the Wait List for Conditioned Improved
There is a disproportionate number of candidates removed for condition improved from the low-volume center wait list ( Table 2 ). The 3 most common diagnoses for removed candidates for improved liver function were acute liver failure (25%), idiopathic etiology (24%), and biliary atresia (14% 
Geographic Variation
We report on variations of lowvolume listings by UNOS region in Table 5 . Low-volume center listings in regions 1, 4, 7, and 11 were overrepresented. Only region 1 is considered disadvantageous in terms of donor allograft supply and demand 23 (Table 5) .
Impact of Individual Centers
We found no significant differences in the outcomes or regression analyses when we accounted for the impact of individual centers.
DISCUSSION
Investigators have established that low case volumes adversely affect survival outcomes in a variety of procedures, from those as simple as inguinal hernia repairs to those as complex as pediatric liver transplantation. [1] [2] [3] [4] [5] [6] [7] [8] [9] Although studies have refuted this assertion, 5 the majority seems to accept the relationship. Overall, this understanding has also been reached in the field of transplantation. A number of researchers have shown better outcomes in high-volume centers for renal, cardiac, and liver transplantations, [18] [19] [20] [21] [22] but others have refuted these assertions. 16, 17 Parallel studies in pediatric renal, cardiac, and liver transplantation have also demonstrated this low-volume-poor outcome relationship. 14, 20, 24 As a result of the general acceptance of this conclusion, insurance companies routinely require a minimum yearly case volume to designate a program as a center of excellence in adult and pediatric transplantation.
25
Our analysis is unique in the body of literature on this topic because it looks beyond survival outcomes into access to transplantation. We do see worse wait-list and posttransplant survival in low-volume pediatric liver transplant centers, but the most profound differences are in the likelihood of transplantation. Lowvolume centers (,5 transplants per year), where 39% of the children are listed, have a smaller transplant rate (41%) than the other centers (85%). This staggering difference in the likelihood of transplantation is exacerbated by poorer wait-list and posttransplant survival in low-
FIGURE 5
Kaplan-Meier curve of intent-to-treat analysis of candidate survival from listing by pediatric liver center volume. P , .05 for each group by log-rank test with reference to ,5 transplants per year. The significant differences in survival outcomes and in the likelihood of transplantation suggest that pediatric liver transplantation should be consolidated in higher volume centers. If substantiated by other studies, this change in policy would not be trivial because 39% of patients are listed in centers performing ,5 transplants per year. We would strongly suggest a policy change to exempt centers serving geographically isolated populations. We did not find significant differences in the likelihood of transplantation or survival outcomes among centers in which $5 transplants were performed per year. However, when we considered our riskiest pediatric recipients (,6 kg and on life support), we found the best outcomes in our highest volume centers (.15 transplants per year).
Since the passage of the National Transplantation Act of 1984, data entry has been mandatory for all US transplant centers. Nevertheless, all patient registries often suffer from variability in data entry. The findings from this study were based on large cohorts of patients and are unlikely to be significantly affected by small amounts of missing data. We attempted to account for missing data with multiple imputation analysis. Another significant limitation was that center-specific factors could not be appropriately accounted for.
CONCLUSIONS
Of pediatric transplant candidates, 38.5% are listed in low-volume transplant centers and have a reduced likelihood of transplantation and poorer outcomes. If further studies substantiated these findings, we would advocate consolidating pediatric liver transplantation in higher volume centers.
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